Is it Possible to Reverse the Endothelial Dysfunction in Pulmonary Arterial Hypertension?⁎⁎Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.-Reference-Cited by-同舟云学术

Is it Possible to Reverse the Endothelial Dysfunction in Pulmonary Arterial Hypertension?⁎⁎Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.

Published:2007-04 Issue:14 Volume:49 Page:1572-1574
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Barst Robyn

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference5 articles.

1. Survival in patients with primary pulmonary hypertension: results from a natural prospective registry;D’Alonzo;Ann Intern Med,1991

2. Diagnosis and management of pulmoanry arterial hypertension: ACCP evidence-based clinical practice guidelines;Rubin;Chest,2004

3. Isolation of putative progenitor endothelial cells for angiogenesis;Asahara;Science,1997

4. Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial;Wang;J Am Coll Cardol,2007

5. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells;Zhao;Circ Res,2005

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stem cell therapy for pulmonary arterial hypertension: An update;The Journal of Heart and Lung Transplantation;2022-06

2. The potential and challenges of using stem cells for cardiovascular repair and regeneration;Genes & Diseases;2014-09

3. Efficacy, safety and clinical pharmacology of macitentan in comparison to other endothelin receptor antagonists in the treatment of pulmonary arterial hypertension;Expert Opinion on Drug Safety;2013-11-22

4. Endothelial Progenitor Cell-Based Therapy for Pulmonary Arterial Hypertension;Cell Transplantation;2013-08

5. Myoendothelial gap junctional signaling induces differentiation of pulmonary arterial smooth muscle cells;American Journal of Physiology-Lung Cellular and Molecular Physiology;2011-10